PPG, PPG Foundation invested $18.4 million in communities worldwide in 2024
19.2.2025 15:00:00 CET | Business Wire | Press release
PPG (NYSE:PPG) and the PPG Foundation today announced that they invested $18.4 million worldwide in 2024, an increase of $900,000 over 2023. The 2024 funding supported more than 400 community partners and programs that focus on advancing education and delivering community sustainability while encouraging PPG employee volunteerism.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250219834296/en/
PPG and the PPG Foundation invested $18.4 million worldwide in 2024 to programs that focus on advancing education and delivering community sustainability while encouraging PPG employee volunteerism. (Photo: Business Wire)
“Around the world, PPG’s 2024 community engagement investments aimed to inspire students and aspiring STEM leaders, beautify neighborhoods and give our employees meaningful ways to give back,” said Malesia Dunn, executive director, PPG Foundation and corporate global social responsibility. “We’re focused on creating brighter communities, inspiring the future workforce and applying our employees’ talents in ways that create tangible impacts.”
Highlights of the 2024 community engagement commitments include:
- $11.5 million to build the next generation of STEM leaders.
- PPG expanded its partnership with the National Museum of Science and Technology Leonardo da Vinci in Milan to open Playlab, a unique educational space for young children.
- PPG entered a two-year partnership with the Foundation for Environmental Education (FEE) to support the creation of materials including “Eco-Schools” handbooks, instructional videos, online courses and training materials for teachers.
- In Pittsburgh and Detroit, the PPG Foundation partnered with nonprofit Code/Art to expand access to computer science programs for girls that blend art and technology.
- In Sumaré, Brazil, PPG launched the third edition of “Girls in Tech,” an initiative with nonprofit Casa Hacker to empower young women to pursue careers in technology.
- Progress toward our commitments.
- $1.2 million invested toward the $5 million commitment by 2030 to environmental sustainability education, supporting organizations such as the National Energy Education Development (NEED) in the U.S., Junior Uni Wuppertal’s sustainability courses in Germany, and the Attitude for the Planet program with Junior Achievement in Brazil.
- PPG completed its $2 million commitment by 2025 to future skilled worker training through organizations including the Bidwell Training Center’s Chemical Laboratory Technician program in the U.S.; technical education program 42KL in Malaysia; donations of PPG LINQ™ innovative tools to vocational schools in Europe; and WorldSkills Lyon 2024, the world’s largest vocational skills competition.
- $6.4 million to community sustainability and disaster relief.
- PPG and the PPG Foundation contributed to organizations supporting emergency relief, including the Red Cross, following natural disasters and extreme weather in the southeastern U.S. and across Europe.
- 58 COLORFUL COMMUNITIES® projects completed in 2024 in 27 countries.
- PPG’s Colorful Communities program has now completed nearly 600 projects since 2015. More than 30,300 PPG employee and community volunteers have positively impacted over 10.2 million people in more than 50 countries.
- Throughout June, July and August 2024, the Colorful Communities program completed its third New Paint for a New Start initiative, transforming 90 schools into engaging environments for nearly 53,000 students and teachers from 2022 to 2024.
Learn more about PPG and the PPG Foundation’s investments in 2024.
PPG’s global community engagement efforts and the PPG Foundation aim to bring color and brightness to PPG communities around the world. We invested $18.4 million in 2024, supporting hundreds of organizations across more than 30 countries. By investing in educational opportunities, we help grow tomorrow’s STEM innovators and skilled workforce in fields related to coatings and manufacturing. Plus, we empower PPG employees to multiply their impact for causes that are important to them by supporting their volunteer efforts and charitable giving. Learn more here.
PPG: WE PROTECT AND BEAUTIFY THE WORLD®
At PPG (NYSE:PPG), we work every day to develop and deliver the paints, coatings and specialty materials that our customers have trusted for more than 140 years. Through dedication and creativity, we solve our customers’ biggest challenges, collaborating closely to find the right path forward. With headquarters in Pittsburgh, we operate and innovate in more than 70 countries and reported net sales of $15.8 billion in 2024. We serve customers in construction, consumer products, industrial and transportation markets and aftermarkets. To learn more, visit www.ppg.com.
PPG LINQ is a trademark and Colorful Communities, the PPG Logo and We protect and beautify the world are registered trademarks of PPG Industries Ohio, Inc.
CATEGORY Community Affairs
View source version on businesswire.com: https://www.businesswire.com/news/home/20250219834296/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom